Medpace Holdings (MEDP) Operating Leases (2019 - 2026)
Medpace Holdings' (MEDP) quarterly Operating Leases came in at $144.1 million in Q2 2026, down 3.82% on a YoY basis from $149.8 million in Q2 2025, and down 1.36% quarter-over-quarter from $146.1 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Operating Leases (2019 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Operating Leases for 8 consecutive years, with $144.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases fell 3.82% year-over-year to $144.1 million; the trailing twelve-month figure through Jun 2026 stood at $144.1 million (down 3.82% YoY), and the FY2025 full-year result was $136.9 million, down 8.47% from the prior year.
- Operating Leases fell to $144.1 million in Q2 2026 per MEDP's latest filing, from $146.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $164.5 million in Q4 2023 and bottomed at $135.0 million in Q2 2022.
- Historically, Operating Leases has averaged $151.5 million across 5 years, with a median of $151.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Operating Leases gained 24.07% in 2022, then dropped 9.1% in 2024.
- Over 5 years, Operating Leases stood at $158.1 million in 2022, then increased by 4.01% to $164.5 million in 2023, then decreased by 9.1% to $149.5 million in 2024, then dropped by 8.47% to $136.9 million in 2025, then grew by 5.31% to $144.1 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $144.1 million, $146.1 million, and $136.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 144.11 Mn |
| Mar 31, 2026 | 146.09 Mn |
| Dec 31, 2025 | 136.85 Mn |
| Sep 30, 2025 | 143.97 Mn |
| Jun 30, 2025 | 149.83 Mn |
| Mar 31, 2025 | 150.35 Mn |
| Dec 31, 2024 | 149.52 Mn |
| Sep 30, 2024 | 151.89 Mn |
| Jun 30, 2024 | 153.73 Mn |
| Mar 31, 2024 | 158.13 Mn |
| Dec 31, 2023 | 164.49 Mn |
| Sep 30, 2023 | 163.32 Mn |
| Jun 30, 2023 | 159.38 Mn |
| Mar 31, 2023 | 161.93 Mn |
| Dec 31, 2022 | 158.14 Mn |
| Sep 30, 2022 | 157.89 Mn |
| Jun 30, 2022 | 134.98 Mn |
| Mar 31, 2022 | 141.62 Mn |
| Dec 31, 2021 | 147.24 Mn |
| Sep 30, 2021 | 128.21 Mn |